Displaying 81 - 100 of 191 results

Living With Lupus: Health Information Basics for You and Your Family

https://www.niams.nih.gov/community-outreach-initiative/understanding-joint-health/living-with-lupus

Lupus is a chronic (long-lasting) autoimmune disease. This webpage focuses on systemic lupus erythematosus (SLE), the most common form of lupus. Lupus is different for each person and can affect different areas of the body, including: skin; joints; heart; lungs; kidneys; and the brain. If you have lupus, you may have times of more symptoms (flares) and times of feeling better (remission).

Scleroderma Genomics and Health Disparities Unit Tables

https://www.niams.nih.gov/labs/scleroderma-genomics-and-health-disparities-lap/tables

« Scleroderma Genomics and Health Disparities Unit Table 1. Clinical Manifestations of scleroderma patients in the GRASP cohort (Morgan, Gourh, et al, Medicine 2017) Diffuse Scleroderma Telangiectasia Calcinosis Pulmonary ∥† Fibrosis FVC% pred † ≤70 Pulmonary ¶† Hypertension Scleroderma Renal Crisis Age at onset 0.99 (0.97-1.00) 0.99 (0.98-1.01) 1.00 (0.98-1.01)

R03 Information for NIAMS K Award Recipients

https://www.niams.nih.gov/grants-funding/research-training-and-career-development-programs/r03-information-niams-k-award

NIAMS Small Grant Program for New Investigators (R03) Read the NOFO: Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed) Program Purpose: The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is seeking small grant (R03) applications to stimulate

NIAMS Remembers Scientist Emeritus Paul Plotz, M.D.

https://www.niams.nih.gov/newsroom/announcements/niams-remembers-scientist-emeritus-paul-plotz-md

NIAMS is saddened to share the news that Paul Plotz, M.D., who dedicated nearly four decades of service to science at the NIH, passed away on January 13, 2024, at the age of 86 after a long illness. Dr. Plotz was a world-renowned rheumatologist, immunologist, and researcher known internationally as an expert in myositis, an inflammatory muscle disease and rare autoimmune condition. He retired from NIH in 2011 after serving in a variety of leadership roles, including as chief of the NIAMS Arthritis and Rheumatism Branch, as well as acting scientific director and acting deputy director. He also was senior

Typically materials from NIAMS that are more than 5 years old will be archived.